Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial
- PMID: 32293940
- PMCID: PMC7193776
- DOI: 10.1200/GO.20.00072
Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial
Conflict of interest statement
Eva Segelov
Hans Prenen
Raina MacIntyre
Raghib Ali
Gilberto de Lima Lopes Jr
Gong Chen
John Whay Kuang Chia
Han Chong Toh
No other potential conflicts of interest were reported.
Figures
References
-
- WHO: Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-...
-
- Munster VJ, Koopmans M, van Doremalen N, et al. A novel coronavirus emerging in China - key questions for impact assessment. N Engl J Med. 2020;382:692–694. - PubMed
-
- WHO: Coronavirus disease (COVID-2019) situation reports. Situation report - 38. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
-
- Mallapaty S. Scientists fear coronavirus spread in countries least able to contain it. Nature. 2020;578:348. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical